(Q38292701)

1 September 2017

title

Ribozyme-mediated downregulation of human metallothionein II(a) induces apoptosis in human prostate and ovarian cancer cell lines (English)

1 reference

1 September 2017

0 references

1 reference

Seshadri Tekur

1

1 reference

1 September 2017

Shuk-Mei Ho

series ordinal

2

1 reference

1 September 2017

language of work or name

1 reference

1 January 2002

1 reference

1 September 2017

published in

Molecular Carcinogenesis

1 reference

1 September 2017

volume

33

1 reference

1 September 2017

issue

1

1 reference

1 September 2017

page(s)

44-55

1 reference

Biochemistry of metallothionein

1 September 2017

cites work

1 reference

Regulation of metallothionein gene expression

21 January 2018

1 reference

Induction, regulation, degradation, and biological significance of mammalian metallothioneins.

21 January 2018

1 reference

Human metallothionein genes are clustered on chromosome 16

21 January 2018

1 reference

Expression and regulation of metallothionein mRNA levels in the prostates of noble rats: lack of expression in the ventral prostate and regulation by sex hormones in the dorsolateral prostate

21 January 2018

1 reference

Significance of metallothionein overexpression in human tumours

21 January 2018

1 reference

Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis

21 January 2018

1 reference

Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours

21 January 2018

1 reference

Metallothionein in radiation exposure: its induction and protective role

21 January 2018

1 reference

The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs

21 January 2018

1 reference

Generation and characterization of hammerhead ribozymes targeting rodent metallothionein-I and -II ribonucleic acid.

21 January 2018

1 reference

Hammerhead ribozyme design and application

21 January 2018

1 reference

Ribozyme and peptide-nucleic acid-based gene therapy

21 January 2018

1 reference

Flow cytometric analysis of G1- and G2/M-phase subpopulations in mammalian cell nuclei using side scatter and DNA content measurements

21 January 2018

1 reference

Protooncogenes as mediators of apoptosis

21 January 2018

1 reference

Cell death signal transduction and Bcl-2 function

21 January 2018

1 reference

Making decisions through Myc.

21 January 2018

1 reference

Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer

21 January 2018

1 reference

Dichotomy of AML1-ETO functions: growth arrest versus block of differentiation

21 January 2018

1 reference

Induction of apoptosis in human leukemia cells by 3-deazaadenosine is mediated by caspase-3-like activity

21 January 2018

1 reference

Effect of saikosaponin, a triterpene saponin, on apoptosis in lymphocytes: association with c-myc, p53, and bcl-2 mRNA.

21 January 2018

1 reference

Sex differences in hepatic and renal cadmium accumulation and metallothionein induction. Role of estradiol

21 January 2018

1 reference

Immunohistochemical study of metallothionein in normal and benign prostatic hyperplasia of human prostate

21 January 2018

1 reference

Immunohistochemical localization of metallothionein in human prostate cancer

21 January 2018

1 reference

Tumor cell growth is inhibited by suppressing metallothionein-I synthesis

21 January 2018

1 reference

Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen

21 January 2018

1 reference

Apoptosis induced by droloxifene and c-myc, bax and bcl-2 mRNA expression in cultured luteal cells of rats

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MC.10017

1 reference

1 September 2017

1 reference